5
AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics www.who.int/hiv/amds J. Perriëns

AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics J. Perriëns

Embed Size (px)

Citation preview

Page 1: AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics  J. Perriëns

AIDS Medicines and Diagnostics Services

- a network of organizations supporting access to HIV medicines

and diagnostics

www.who.int/hiv/amds

J. Perriëns

Page 2: AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics  J. Perriëns

Medicines• Access to ARV in LMIC report + FB• Increasing access to ARV in MIC• Forecast of ARV demand• Price benchmarks for ARVs in GPRM+ summary report• Price info for MIC HIV& HCV meds and diagnostics• Regulatory status of ARVs • Production capacity and price of ARV API

Database on procurement of HIV and Hepatitis products* *(Additional data currently not included in the Global Price Reporting Mechanism)

Page 3: AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics  J. Perriëns

Type date

MedicinesChallenges:• Hepatitis C, hepatitis B infomediary• Access to third line and pipeline HIV drugs• Continuity of GPRM• www.psmtoolbox.org

Page 4: AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics  J. Perriëns

Diagnostics – Rational procurement and deployment of

diagnostics: "bundles" – global report + country feedback on CD4 and VL technology use

– Diagnostics Access Initiative: forecasting – Price reporting ---> GPRM– SLIPTA in Africa and Europe – "normative" products

HABIYAMBERE, Vincent
medicines is not CDC expertise. we should limit to access to diagnostics
HABIYAMBERE, Vincent
CDC provided technical inputs Yes, but I would delet took the lead in WHO context as taking the lead is not support.
Page 5: AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics  J. Perriëns

Diagnostics– Maintain support – at risk areas include:• procurement guide• inclusion of diagnostics in GPRM

– Expand it to include• hepatitis diagnostics• support for VL roll out in Asia• operational guidance on roll out of POC CD4 and VL

technology